Google
Trusted Resources: News & Events
Latest announcements and gatherings
Expert Opinion Hydroxyurea Could Prevent Strokes for People With Sickle Cell Disease in Lieu of Transfusions During COVID-19 Blood Supply Shortage
The COVID-19 pandemic threatens to cause a blood supply shortage in the United States, and as a result, clinicians may be compelled to ration or conserve blood products. For people living with sickle cell disease (SCD), blood transfusions are often necessary to decrease the frequency of severe symptoms.
In a new Blood paper, Michael R. DeBaun, MD, MPH, of Vanderbilt University Medical Center, Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, suggests that while monthly blood transfusions are the standard method of stroke prevention for children with SCD and at high risk of strokes, initiation of hydroxyurea therapy may be an effective alternative, if the monthly blood transfusions are interrupted.
+myBinderRelated Content
-
Information About COVID-19 for Sickle Cell Disease PatientsCOVID-19, short for coronavirus disease ...
-
The Role of Caregivers in Sickle Cell Disease and the Impact of COVID-19We are excited to present our Seventh An...
-
Rumor, Disparity and Distrust: Why Black Americans Face an Uphill Battle Against COVID-19AFTER TESTING POSITIVE for COVID-19, su...
-
COVID-19 and Sickle Cell Disease – Biree Andemariam, MDhttps://www.youtube.com/watch?v=mZ_yfFyQ...
-
CDC Updates, Expands List of People at Risk of Severe COVID-19 IllnessOlder adults and people with underlying ...
-
Listening to Sickle Cell Patients is Crucial During a CrisisI recently was admitted to the hospital ...
-
You Should Get a COVID-19 Vaccine – Haitian Creolehttps://www.youtube.com/watch?v=_vSN2TWM...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.